 | • レポートコード：D0804-14716 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アルツハイマー病診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。アルツハイマー病診断の種類別市場規模（遺伝子検査、神経学的検査、ミニメンタルステート検査（MMSE）、脳イメージング、その他）、用途別市場規模（クリニック、病院、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Accera、TauRx、Cognition Therapeutics、Alector、Neuro-Bio、Treventis ・地域別グローバル市場分析 2015年-2020年 ・アルツハイマー病診断の北米市場（アメリカ、カナダ、メキシコ） ・アルツハイマー病診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アルツハイマー病診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アルツハイマー病診断の南米市場（ブラジル、アルゼンチン） ・アルツハイマー病診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：遺伝子検査、神経学的検査、ミニメンタルステート検査（MMSE）、脳イメージング、その他 ・用途別分析：クリニック、病院、診断センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Alzheimer’s Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Alzheimer’s Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Alzheimer’s Disease Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alzheimer’s Disease Diagnostic market has been segmented into:
Genetic testing
Neurological exam
Mini-mental state exam (MMSE)
Brain imaging
Other
By Application, Alzheimer’s Disease Diagnostic has been segmented into:
Clinics
Hospitals
Diagnostic Centers
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alzheimer’s Disease Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Alzheimer’s Disease Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alzheimer’s Disease Diagnostic market.
The report offers in-depth assessment of the growth and other aspects of the Alzheimer’s Disease Diagnostic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Alzheimer’s Disease Diagnostic Market Share Analysis
Alzheimer’s Disease Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alzheimer’s Disease Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alzheimer’s Disease Diagnostic sales, revenue and market share for each player covered in this report.
The major players covered in Alzheimer’s Disease Diagnostic are:
Eli Lilly
Accera
TauRx
Cognition Therapeutics
Alector
Neuro-Bio
Treventis
Table of Contents
1 Alzheimer’s Disease Diagnostic Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Diagnostic
1.2 Classification of Alzheimer’s Disease Diagnostic by Type
1.2.1 Global Alzheimer’s Disease Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type in 2019
1.2.3 Genetic testing
1.2.4 Neurological exam
1.2.5 Mini-mental state exam (MMSE)
1.2.6 Brain imaging
1.2.7 Other
1.3 Global Alzheimer’s Disease Diagnostic Market by Application
1.3.1 Overview: Global Alzheimer’s Disease Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Global Alzheimer’s Disease Diagnostic Market by Regions
1.4.1 Global Alzheimer’s Disease Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Alzheimer’s Disease Diagnostic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Alzheimer’s Disease Diagnostic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Alzheimer’s Disease Diagnostic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alzheimer’s Disease Diagnostic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Alzheimer’s Disease Diagnostic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alzheimer’s Disease Diagnostic Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Accera
2.2.1 Accera Details
2.2.2 Accera Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Accera SWOT Analysis
2.2.4 Accera Product and Services
2.2.5 Accera Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.3 TauRx
2.3.1 TauRx Details
2.3.2 TauRx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 TauRx SWOT Analysis
2.3.4 TauRx Product and Services
2.3.5 TauRx Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cognition Therapeutics
2.4.1 Cognition Therapeutics Details
2.4.2 Cognition Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cognition Therapeutics SWOT Analysis
2.4.4 Cognition Therapeutics Product and Services
2.4.5 Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alector
2.5.1 Alector Details
2.5.2 Alector Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alector SWOT Analysis
2.5.4 Alector Product and Services
2.5.5 Alector Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Neuro-Bio
2.6.1 Neuro-Bio Details
2.6.2 Neuro-Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Neuro-Bio SWOT Analysis
2.6.4 Neuro-Bio Product and Services
2.6.5 Neuro-Bio Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Treventis
2.7.1 Treventis Details
2.7.2 Treventis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Treventis SWOT Analysis
2.7.4 Treventis Product and Services
2.7.5 Treventis Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Alzheimer’s Disease Diagnostic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Alzheimer’s Disease Diagnostic Players Market Share
3.2.2 Top 10 Alzheimer’s Disease Diagnostic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Regions
4.2 North America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.3 Europe Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.5 South America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
5 North America Alzheimer’s Disease Diagnostic Revenue by Countries
5.1 North America Alzheimer’s Disease Diagnostic Revenue by Countries (2015-2020)
5.2 USA Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
5.3 Canada Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
5.4 Mexico Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
6 Europe Alzheimer’s Disease Diagnostic Revenue by Countries
6.1 Europe Alzheimer’s Disease Diagnostic Revenue by Countries (2015-2020)
6.2 Germany Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.3 UK Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.4 France Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.5 Russia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
6.6 Italy Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Countries
7.1 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Countries (2015-2020)
7.2 China Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.3 Japan Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.4 Korea Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.5 India Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
8 South America Alzheimer’s Disease Diagnostic Revenue by Countries
8.1 South America Alzheimer’s Disease Diagnostic Revenue by Countries (2015-2020)
8.2 Brazil Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
8.3 Argentina Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Alzheimer’s Disease Diagnostic by Countries
9.1 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
9.3 UAE Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
9.4 Egypt Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
9.5 South Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2015-2020)
10.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Type (2019-2024)
10.3 Genetic testing Revenue Growth Rate (2015-2025)
10.4 Neurological exam Revenue Growth Rate (2015-2025)
10.5 Mini-mental state exam (MMSE) Revenue Growth Rate (2015-2025)
10.6 Brain imaging Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Alzheimer’s Disease Diagnostic Market Segment by Application
11.1 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2015-2020)
11.2 Alzheimer’s Disease Diagnostic Market Forecast by Application (2019-2024)
11.3 Clinics Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Alzheimer’s Disease Diagnostic Market Size Forecast (2021-2025)
12.1 Global Alzheimer’s Disease Diagnostic Market Size Forecast (2021-2025)
12.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Regions (2021-2025)
12.3 North America Alzheimer’s Disease Diagnostic Revenue Market Forecast (2021-2025)
12.4 Europe Alzheimer’s Disease Diagnostic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue Market Forecast (2021-2025)
12.6 South America Alzheimer’s Disease Diagnostic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Alzheimer's Disease Diagnostic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alzheimer's Disease Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alzheimer's Disease Diagnostic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Alzheimer's Disease Diagnostic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Alzheimer's Disease Diagnostic Major Business
Table 7. Eli Lilly Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Alzheimer's Disease Diagnostic Product and Solutions
Table 10. Eli Lilly Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Accera Corporate Information, Location and Competitors
Table 12. Accera Alzheimer's Disease Diagnostic Major Business
Table 13. Accera Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2018-2019)
Table 14. Accera SWOT Analysis
Table 15. Accera Alzheimer's Disease Diagnostic Product and Solutions
Table 16. Accera Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. TauRx Corporate Information, Location and Competitors
Table 18. TauRx Alzheimer's Disease Diagnostic Major Business
Table 19. TauRx Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 20. TauRx SWOT Analysis
Table 21. TauRx Alzheimer's Disease Diagnostic Product and Solutions
Table 22. TauRx Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Cognition Therapeutics Corporate Information, Location and Competitors
Table 24. Cognition Therapeutics Alzheimer's Disease Diagnostic Major Business
Table 25. Cognition Therapeutics Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 26. Cognition Therapeutics SWOT Analysis
Table 27. Cognition Therapeutics Alzheimer's Disease Diagnostic Product and Solutions
Table 28. Cognition Therapeutics Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Alector Corporate Information, Location and Competitors
Table 30. Alector Alzheimer's Disease Diagnostic Major Business
Table 31. Alector Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 32. Alector SWOT Analysis
Table 33. Alector Alzheimer's Disease Diagnostic Product and Solutions
Table 34. Alector Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Neuro-Bio Corporate Information, Location and Competitors
Table 36. Neuro-Bio Alzheimer's Disease Diagnostic Major Business
Table 37. Neuro-Bio Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 38. Neuro-Bio SWOT Analysis
Table 39. Neuro-Bio Alzheimer's Disease Diagnostic Product and Solutions
Table 40. Neuro-Bio Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Treventis Corporate Information, Location and Competitors
Table 42. Treventis Alzheimer's Disease Diagnostic Major Business
Table 43. Treventis Alzheimer's Disease Diagnostic Total Revenue (USD Million) (2017-2018)
Table 44. Treventis SWOT Analysis
Table 45. Treventis Alzheimer's Disease Diagnostic Product and Solutions
Table 46. Treventis Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Alzheimer's Disease Diagnostic Revenue (Million USD) by Players (2015-2020)
Table 48. Global Alzheimer's Disease Diagnostic Revenue Share by Players (2015-2020)
Table 49. Global Alzheimer's Disease Diagnostic Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Alzheimer's Disease Diagnostic Revenue Market Share by Regions (2015-2020)
Table 51. North America Alzheimer's Disease Diagnostic Revenue by Countries (2015-2020)
Table 52. North America Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Table 53. Europe Alzheimer's Disease Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Alzheimer's Disease Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Alzheimer's Disease Diagnostic Revenue by Countries (2015-2020)
Table 56. South America Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Alzheimer's Disease Diagnostic Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Table 59. Global Alzheimer's Disease Diagnostic Revenue (Million USD) by Type (2015-2020)
Table 60. Global Alzheimer's Disease Diagnostic Revenue Share by Type (2015-2020)
Table 61. Global Alzheimer's Disease Diagnostic Revenue Forecast by Type (2021-2025)
Table 62. Global Alzheimer's Disease Diagnostic Revenue by Application (2015-2020)
Table 63. Global Alzheimer's Disease Diagnostic Revenue Share by Application (2015-2020)
Table 64. Global Alzheimer's Disease Diagnostic Revenue Forecast by Application (2021-2025)
Table 65. Global Alzheimer's Disease Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Alzheimer's Disease Diagnostic Picture
Figure 2. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type in 2019
Figure 3. Genetic testing Picture
Figure 4. Neurological exam Picture
Figure 5. Mini-mental state exam (MMSE) Picture
Figure 6. Brain imaging Picture
Figure 7. Other Picture
Figure 8. Alzheimer's Disease Diagnostic Revenue Market Share by Application in 2019
Figure 9. Clinics Picture
Figure 10. Hospitals Picture
Figure 11. Diagnostic Centers Picture
Figure 12. Other Picture
Figure 13. Global Alzheimer's Disease Diagnostic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Alzheimer's Disease Diagnostic Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Alzheimer's Disease Diagnostic Revenue Market Share in 2019
Figure 22. Global Top 10 Players Alzheimer's Disease Diagnostic Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Alzheimer's Disease Diagnostic Revenue Market Share by Regions (2015-2020)
Figure 26. Global Alzheimer's Disease Diagnostic Revenue Market Share by Regions in 2018
Figure 27. North America Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 28. Europe Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 30. South America Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 32. North America Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 33. North America Alzheimer's Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 34. USA Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 35. Canada Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 37. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 39. Germany Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 40. UK Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 41. France Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 42. Russia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 43. Italy Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 46. China Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 47. Japan Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 48. Korea Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 49. India Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 51. South America Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 52. South America Alzheimer's Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 53. Brazil Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 58. UAE Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Alzheimer's Disease Diagnostic Revenue and Growth Rate (2015-2020)
Figure 61. Global Alzheimer's Disease Diagnostic Revenue Share by Type (2015-2020)
Figure 62. Global Alzheimer's Disease Diagnostic Revenue Share by Type in 2019
Figure 63. Global Alzheimer's Disease Diagnostic Market Share Forecast by Type (2021-2025)
Figure 64. Global Genetic testing Revenue Growth Rate (2015-2020)
Figure 65. Global Neurological exam Revenue Growth Rate (2015-2020)
Figure 66. Global Mini-mental state exam (MMSE) Revenue Growth Rate (2015-2020)
Figure 67. Global Brain imaging Revenue Growth Rate (2015-2020)
Figure 68. Global Other Revenue Growth Rate (2015-2020)
Figure 69. Global Alzheimer's Disease Diagnostic Revenue Share by Application (2015-2020)
Figure 70. Global Alzheimer's Disease Diagnostic Revenue Share by Application in 2019
Figure 71. Global Alzheimer's Disease Diagnostic Market Share Forecast by Application (2021-2025)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Alzheimer's Disease Diagnostic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Alzheimer's Disease Diagnostic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Alzheimer's Disease Diagnostic Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Alzheimer's Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 80. Europe Alzheimer's Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Alzheimer's Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 82. South America Alzheimer's Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
認知症・アルツハイマー病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dementia and Alzheimer’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…- 呼吸器疾患検査の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Respiratory Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Disea…
- パーキンソン病脳深部刺激・サービスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Deep Brain Stimulation and Service for Parkinson’s Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global mark…
- フォンウィルブランド病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Von Willebrand Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Von Willebra…
- ウィルソン病治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Wilson's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wilson's Disease Drugs…